Mechanisms of topoisomerase I inhibition by anticancer drugs.
Pommier
Y
Y
National Institutes of Health, Bethesda, Maryland 20892, USA.
Tanizawa
A
A
Kohn
K W
KW
D000818:Animals; D000972:Antineoplastic Agents, Phytogenic / Q000494:pharmacology*; D002166:Camptothecin / Q000494:pharmacology*; D004249:DNA Damage; D004273:DNA, Neoplasm / Q000187:drug effects*; D006801:Humans; D059004:Topoisomerase I Inhibitors
D000972:Antineoplastic Agents, Phytogenic; D004273:DNA, Neoplasm; D059004:Topoisomerase I Inhibitors; D002166:Camptothecin